| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 134.17B | 126.90B | 113.47B | 94.18B | 81.08B | 58.78B |
| Gross Profit | 73.33B | 69.29B | 57.39B | 42.13B | 34.03B | 23.81B |
| EBITDA | 23.88B | 17.74B | 14.59B | -5.41B | -71.65B | -112.11B |
| Net Income | 16.14B | 15.34B | 6.40B | -13.69B | -78.08B | -116.64B |
Balance Sheet | ||||||
| Total Assets | 155.54B | 139.87B | 106.30B | 89.31B | 92.52B | 52.15B |
| Cash, Cash Equivalents and Short-Term Investments | 57.15B | 51.50B | 48.86B | 35.41B | 45.28B | 26.81B |
| Total Debt | 36.53B | 29.53B | 15.72B | 12.93B | 13.61B | 5.71B |
| Total Liabilities | 84.82B | 77.85B | 57.22B | 49.47B | 47.42B | 212.20B |
| Stockholders Equity | 70.70B | 62.00B | 49.06B | 39.83B | 45.09B | -160.05B |
Cash Flow | ||||||
| Free Cash Flow | 10.70B | 21.72B | 15.88B | -2.42B | -13.28B | -3.62B |
| Operating Cash Flow | 16.38B | 29.79B | 20.78B | 2.20B | -5.52B | 2.29B |
| Investing Cash Flow | -17.95B | -36.68B | -19.86B | -17.55B | -18.36B | -4.87B |
| Financing Cash Flow | 2.87B | 6.71B | -1.36B | -4.48B | 36.50B | 19.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$196.58B | 13.56 | 25.44% | ― | 11.37% | 16.74% | |
73 Outperform | HK$105.08B | 17.65 | 14.05% | 1.01% | 13.62% | 80.52% | |
65 Neutral | HK$4.35T | 22.32 | 20.51% | 0.75% | 13.15% | 30.78% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | HK$16.29B | 12.92 | 3.33% | 9.97% | -5.74% | -14.46% | |
60 Neutral | HK$16.39B | 5.39 | 12.13% | 8.13% | -1.40% | 22.37% | |
53 Neutral | HK$278.63B | 59.14 | 2.02% | ― | -2.92% | -57.12% |